Takara Bio Europe launches Cellartis® MSC EV Wonder™, a defined, xeno-free medium for high-yield EV production - bioinformant.com/takara-bio-e...

Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research - bioinformant.com/ncardia-ipsc...

Congress Moves to Reauthorize Funding for National Cord Blood and Bone Marrow Transplant Programs - bioinformant.com/fundering-co...

Precision Over Hype: Biogenomics’ Genovia Sets a New Standard in #Exosome-Based Regenerative Aesthetics - bioinformant.com/precision-ov...

Sanatela AT Medical Solutions Inc. Announces Groundbreaking Patent Issuance for Cancer Stem Cell Identification and Precision Treatment Platform - bioinformant.com/sanatela-at-...

Shineco Establishes Biological Cell Digital Division to Integrate iPSC Technology Assets with Blockchain Technology - bioinformant.com/shineco-biol...

AABB’s Cell and Gene Therapy Standards for Pharmacy, First Edition, Takes Effect October 1 - bioinformant.com/aabbs-cell-a... @aabbupdates.bsky.social

Cord Blood Industry Consolidation Escalates in 2025 - bioinformant.com/cord-blood-i...

EU Grants Approval to Zemcelpro, a Cord Blood–Derived Stem Cell Therapy for Blood Cancer Patients - bioinformant.com/eu-grants-ap...

Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards - bioinformant.com/cartherics-m...

I'm excited to announce the 5th iPSC Drug Development Summit (Oct 1–2, 2025, Boston), the industry’s leading forum advancing iPSC-derived therapies hosted by Hanson Wade. ipsc-therapies-summit.com/about/about-... #ipscells #drugdiscovery #drugdevelopment

Mirugen Secures A$4.5M to Advance In Vivo Cell (Re)programming, Positioning Itself as a Pioneer in the Field - bioinformant.com/mirugen-secu...

Regenerelle® Issues Response to FDA Untitled Letter - bioinformant.com/regenerelle-... Regenerelle®, a leader in Wharton’s Jelly Mesenchymal Stromal Cells (WJ-MSCs) & exosomes derived from WJ-MSCs, announced the public release of its full response to the U.S. FDA Untitled Letter dated May 22, 2023.

Gameto Secures $44M Series C to Advance Fertilo as First iPSC-Derived Reproductive Therapy to Reach Phase 3 in the U.S. - bioinformant.com/gametos-ipsc...

The Scalable Solution for 10X Exosome Yield: AgentV-DSP AgentV™-DSP, a solution from RoosterBio, is designed to prevent filter fouling and deliver novel processing advantages, including greater filter loading capacity and higher #exosome yield. www.roosterbio.com/products/age...

Novel iPSC-Based Vaccine Shows Promise Against Colorectal Cancer - bioinformant.com/novel-ipsc-b...

Japan Moves Toward Permitting Fertilized Embryo Research Using iPSC-Derived Eggs and Sperm - bioinformant.com/japan-fertil...

How CellPort Is Making Cell Culture Smarter – Interview with Patrick Dentinger, CEO of CellPort Software - bioinformant.com/patrick-dent...

Cellino’s iPSC Manufacturing Technology Receives FDA Advanced Manufacturing Technology (AMT) Designation - bioinformant.com/cellinos-ips...

Now Available: Recombinant Human FGF-2 TOP® GMP - nucleusbiologics.com/supplements-... Nucleus Biologics has launched the first and only GMP and thermostable FGF-2 expressed in plants on the market—delivering a lower-cost, GMP-quality solution for the growth of stem cells and adherent HEK cells.

Exosome-Based Therapeutic Development Summit: Accelerate Therapeutic Efficacy and Delivery Potential of Exosomes and EVs - ter.li/ntrzgz

REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research - bioinformant.com/reprocells-i... @reprocell.bsky.social

TriHaz Solutions Opens New Nashville, Tennessee Facility to Expand Regulated Medical Waste Services Across Tennessee - bioinformant.com/trihaz-solut...

First-in-Human Trial of OpCT-001: An iPSC-Derived Cell Therapy for Primary Photoreceptor Diseases - bioinformant.com/bluerock-the...

Incucyte® CX3 System transforms continuous analysis of 3D cell models with confocal imaging and unmatched throughput - bioinformant.com/incucyte-cx3...

Longeveron® Announces Licensing of New Cardiac Selective iPSC Technology for Cardiovascular Disease - bioinformant.com/longeveron-a...

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development - bioinformant.com/ubrigene-lau...

Future Medical Products LLC Announces the Launch of PBME Topical™ (Pure Bone Marrow Exosomes) - bioinformant.com/pure-bone-ma...

Induced Pluripotent Stem Cell (iPSC) Industry Trends Dominating in 2025 - bioinformant.com/ipsc-industr... @riken-brc-en.bsky.social @reprocell.bsky.social @evotec.bsky.social @thermofishersci.bsky.social

UniXell does first patient with an autologous iPSC-based cell therapy (UX-DA001) for Parkinson’s disease in Phase 1 study - bioinformant.com/unixell-biot...

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - bioinformant.com/cellistic-st...

Vita Therapeutics and I Peace announced a development program to generate iPS- derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells - bioinformant.com/vita-therape...

Ciloa has secured €6.5 million government funding from France 2030 ‘Innovation in biotherapies and biomanufacturing’ to develop drug candidate for treatment of obesity and type 2 diabetes - bioinformant.com/ciloa-secure...

REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research -https://bioinformant.com/reprocells-ipsc-seed-stock-clones/ @reprocell.bsky.social

Cell & Gene Therapy Developers Need an Excipient-Certified Cell Culture Media Manufacturer - In cell and gene therapy, product safety and consistency are non-negotiable. nucleusbiologics.com/blog/acceler...

Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research - bioinformant.com/hiex-researc...

Winner of the “Biotherapies and Bioproduction” Call for Projects Under the France 2030 plan, EVerZom Receives €3M in Government Funding to Industrialize its #Exosome Bioproduction Technology - bioinformant.com/everzom-fran...

L2 Bio Seeks Principal Investigators for FDA-Approved Phase 2B Clinical Trial of Adipose-Derived Stem Cell Treatment for Crohn’s Disease - bioinformant.com/l2-bio-seeks...

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics - bioinformant.com/lift-bioscie... @giftoflife.bsky.social

Applied StemCell Launches Two New Hypoimmunogenic hiPSC Products to Accelerate Allogeneic Cell Therapy Development - bioinformant.com/applied-stem...

CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease - bioinformant.com/chu-toulouse...

Altaris Launches Minaris Advanced Therapies, Merging the CDMOs Minaris Regenerative Medicine and WuXi Advanced Therapies - bioinformant.com/altaris-laun...

Pioneering the future of sports with iPS cells - FUNROOTS, I Peace, and Reju form a strategic alliance - bioinformant.com/funroots-i-p...

Global Exosome-Based Aesthetics (Cosmeceuticals) Market - bioinformant.com/global-exoso...

Curi Bio and Cook MyoSite Announce Strategic Partnership - bioinformant.com/curi-bio-and...

Nikon CeLL Innovation Enters into a Strategic License Agreement with RoosterBio, a US Company, to Enable GCTP/GMP Manufacturing Platform of Human Mesenchymal Stem Cells & Extracellular Vesicle in Japan - bioinformant.com/nikon-cell-i...

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - bioinformant.com/roosterbio-c... @thermofishersci.bsky.social

Global Demand for CAR-T Cell Therapies by Product in 2025 - bioinformant.com/car-t-cell-t... @novartis.bsky.social

Designer Exosomes: The Future of Targeted Therapy and Regenerative Medicine - bioinformant.com/designer-exo...

I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S. – Age-Reversed Stem Cell Technology Now Available to the Public – bioinformant.com/i-peace-ips-...